Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


PASSERI DANIEL R Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 3,000 shares @ $2.86, valued at $8.6k
07/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 32,122 shares @ $4.88, valued at $156.8k
Gifted 10,000 shares @ $0
Exercised 75,000 restricted stock units @ $0
03/29/2022 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 100,000 options to buy @ $5.01, valued at $501k
10/08/2021 4 PASSERI DANIEL R (CEO) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Paid exercise price by delivering 31,677 shares @ $14.57, valued at $461.5k
Exercised 75,000 restricted stock units @ $0
09/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2019 4 PASSERI DANIEL R (CEO and President) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 1,377 shares @ $7.26, valued at $10k
06/07/2019 4 PASSERI DANIEL R (CEO and President) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 3,000 shares @ $6.9, valued at $20.7k
03/08/2019 4 PASSERI DANIEL R (CEO and President) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 125,000 options to buy @ $6.42, valued at $802.5k
Granted 100,000 options to buy @ $11.54, valued at $1.2M
08/20/2018 4 PASSERI DANIEL R (CEO and President) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 6,000 shares @ $8.085, valued at $48.5k
06/29/2018 4 PASSERI DANIEL R (CEO and President) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Bought 1,600 shares @ $11.97, valued at $19.2k
12/27/2017 3 PASSERI DANIEL R (CEO and President) has filed a Form 3 on Cue Biopharma, Inc.
01/21/2016 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Granted 50,000 options to buy @ $1.76, valued at $88k
01/07/2016 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Exercised 12,900 options to buy @ $1.57, valued at $20.3k
12/30/2015 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Sold 11,200 shares @ $2.91, valued at $32.6k
Sold 14,400 shares @ $3.01, valued at $43.3k
Exercised 11,200 options to buy @ $1.57, valued at $17.6k
Exercised 14,400 options to buy @ $1.57, valued at $22.6k
12/29/2015 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Sold 2,600 shares @ $2.9, valued at $7.5k
Sold 11,000 shares @ $2.84, valued at $31.2k
Exercised 2,600 options to buy @ $1.57, valued at $4.1k
Exercised 11,000 options to buy @ $1.57, valued at $17.3k
12/23/2015 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Sold 38,000 shares @ $2.75, valued at $104.5k
Sold 10,900 shares @ $2.9, valued at $31.6k
Exercised 38,000 options to buy @ $1.57, valued at $59.7k
Exercised 10,900 options to buy @ $1.57, valued at $17.1k
12/21/2015 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Sold 189,000 shares @ $3.05, valued at $576.5k
Sold 100,000 shares @ $2.87, valued at $287k
Exercised 189,000 options to buy @ $1.57, valued at $296.7k
Exercised 100,000 options to buy @ $1.57, valued at $157k
01/28/2015 4 PASSERI DANIEL R (Director) has filed a Form 4 on CURIS INC
Txns: Granted 25,000 options to buy @ $1.94, valued at $48.5k
02/20/2014 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Granted 100,000 options to buy @ $3.09, valued at $309k
Granted 200,000 options to buy @ $3.09, valued at $618k
05/08/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/08/2013 4/A PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Sold 50,000 shares @ $3.66, valued at $183k
Sold 65,000 shares @ $3.73, valued at $242.5k
Sold 60,000 shares @ $3.66, valued at $219.6k
Exercised 50,000 options to buy @ $2.43, valued at $121.5k
Exercised 65,000 options to buy @ $2.43, valued at $158k
Exercised 60,000 options to buy @ $2.43, valued at $145.8k
05/06/2013 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Sold 50,000 shares @ $3.66, valued at $183k
Sold 65,000 shares @ $3.73, valued at $242.5k
Paid exercise price by delivering 135,000 shares @ $3.63, valued at $490.1k
Sold 60,000 shares @ $3.66, valued at $219.6k
Exercised 50,000 options to buy @ $2.43, valued at $121.5k
Exercised 65,000 options to buy @ $2.43, valued at $158k
Exercised 211,452 options to buy @ $2.43, valued at $513.8k
Exercised 51,215 options to buy @ $2.43, valued at $124.5k
01/18/2013 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Granted 12,501 options to buy @ $3.32, valued at $41.5k
Granted 187,499 options to buy @ $3.32, valued at $622.5k
12/07/2012 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Bought 25,000 shares @ $3.03, valued at $75.8k
05/02/2012 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Sold 57,837 shares @ $4.83, valued at $279.4k
Sold 16,813 shares @ $4.83, valued at $81.2k
Sold 36,000 shares @ $4.8, valued at $172.8k
Exercised 57,837 options to buy @ $1.5, valued at $86.8k
Exercised 16,813 options to buy @ $1.09, valued at $18.3k
Exercised 36,000 options to buy @ $1.09, valued at $39.2k
03/21/2012 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Exercised 37,313 options to buy @ $1.5, valued at $56k
Exercised 23,437 options to buy @ $1.09, valued at $25.5k
01/10/2011 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC
Txns: Granted 92,324 options to buy @ $2.15, valued at $198.5k
Granted 107,676 options to buy @ $2.15, valued at $231.5k
02/04/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/06/2009 4 PASSERI DANIEL R (CEO and Director) has filed a Form 4 on CURIS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy